BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27062639)

  • 1. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
    Shan N; Xu PF
    Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
    Chiba Y
    Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large sample bounds on the survivor average causal effect in the presence of a binary covariate with conditionally ignorable treatment assignment.
    Freiman MH; Small DS
    Int J Biostat; 2014; 10(2):143-63. PubMed ID: 25294716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative monotonicity assumptions for improving bounds on natural direct effects.
    Chiba Y; Taguri M
    Int J Biostat; 2013 Jul; 9(2):235-49. PubMed ID: 23893690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-parametric bounds on treatment effects with non-compliance by covariate adjustment.
    Cai Z; Kuroki M; Sato T
    Stat Med; 2007 Jul; 26(16):3188-204. PubMed ID: 17136775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to spillover effects in cluster randomized trials with noncompliance.
    Keele L; Kang H
    Clin Trials; 2022 Aug; 19(4):375-379. PubMed ID: 35510562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sharpening bounds on principal effects with covariates.
    Long DM; Hudgens MG
    Biometrics; 2013 Dec; 69(4):812-9. PubMed ID: 24245800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating causal effects of treatment in RCTs with provider and subject noncompliance.
    Sheng E; Li W; Zhou XH
    Stat Med; 2019 Feb; 38(5):738-750. PubMed ID: 30347462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity.
    Yin Y; Cai Z; Zhou XH
    Biom J; 2018 Sep; 60(5):879-892. PubMed ID: 29911355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instruments and bounds for causal effects under the monotonic selection assumption.
    Taguri M; Chiba Y
    Int J Biostat; 2012 Aug; 8(1):24. PubMed ID: 22944723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of treatment noncompliance on power in a 2 x 2 factorial design.
    Lindblad AS
    J Biopharm Stat; 1996 Jul; 6(3):263-70. PubMed ID: 8854231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
    Chiba Y
    Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using survival information in truncation by death problems without the monotonicity assumption.
    Yang F; Ding P
    Biometrics; 2018 Dec; 74(4):1232-1239. PubMed ID: 29665626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handling missing data in randomized experiments with noncompliance.
    Jo B; Ginexi EM; Ialongo NS
    Prev Sci; 2010 Dec; 11(4):384-96. PubMed ID: 20379779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 20. Applying optimal model selection in principal stratification for causal inference.
    Odondi L; McNamee R
    Stat Med; 2013 May; 32(11):1815-28. PubMed ID: 23042517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.